Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EEG source activity during processing of neutral stimuli in subjects with anxiety disorders.

Acta neurobiologiae experimentalis·2016
Same author

Sleepwalking episodes are preceded by arousal-related activation in the cingulate motor area: EEG current density imaging.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2015
Same author

Age-dependent symptomatology of depression in hospitalized patients and its implications for DSM-5.

Journal of affective disorders·2013
Same author

Cognitive functions in abstinent alcohol-dependent patients.

Alcohol (Fayetteville, N.Y.)·2012
Same author

Serum cortisol concentration in patients with major depression after treatment with fluoxetine.

Psychiatry research·2012
Same author

Waking EEG in primary insomnia.

Acta neurobiologiae experimentalis·2011
Same journal

Effectiveness of a day treatment program for negative symptoms in patients with schizophrenia.

Psychiatria polska·2026
Same journal

Mediating role of unfavorable distribution of resources in association between sense of hopelessness and intensity of self-aggression in problematic substance users.

Psychiatria polska·2026
Same journal

Internet-based cognitive-behavioral therapy for obsessive-compulsive disorder - a literature review.

Psychiatria polska·2026
Same journal

Is there a relationship between insomnia, stress, and job burnout among health care workers?

Psychiatria polska·2026
Same journal

The negative consequences of indirect trauma exposure in professionals - the psychometric properties of the Secondary Traumatic Stress Inventory.

Psychiatria polska·2026
Same journal

Case report: Could hikikomori be a specific presentation of psychotic decompensation in people with autism spectrum disorder?

Psychiatria polska·2026
See all related articles

Related Experiment Video

Updated: May 9, 2026

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
06:23

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

[Cognitive behavioral therapy for chronic insomnia].

Małgorzata Fornal-Pawłowska1, Waldemar Szelenberger

  • 1Katedra i Klinika Psychiatryczna WUM Kierownik.

Psychiatria Polska
|July 30, 2013
PubMed
Summary
This summary is machine-generated.

Cognitive Behavioral Therapy for Insomnia (CBT-I) significantly improved sleep quality and daytime functioning in chronic insomnia patients. These benefits were sustained long-term, with most patients showing clinically meaningful improvement.

More Related Videos

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
05:34

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders

Published on: August 18, 2023

Related Experiment Videos

Last Updated: May 9, 2026

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
06:23

A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice

Published on: September 22, 2020

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
05:34

Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders

Published on: August 18, 2023

Area of Science:

  • Sleep Medicine
  • Behavioral Therapy
  • Psychiatry

Background:

  • Chronic insomnia significantly impacts quality of life and daytime functioning.
  • Cognitive Behavioral Therapy for Insomnia (CBT-I) is a non-pharmacological treatment approach.
  • Evaluating CBT-I's efficacy in a controlled study is crucial for understanding its therapeutic potential.

Purpose of the Study:

  • To assess the effectiveness of Cognitive Behavioral Therapy for Insomnia (CBT-I) in treating chronic insomnia.
  • To compare sleep parameters and psychological outcomes in insomnia patients treated with CBT-I versus healthy controls.
  • To determine the long-term sustainability of CBT-I treatment effects.

Main Methods:

  • A randomized controlled trial involving 51 chronic insomnia patients and 51 matched healthy controls.
  • CBT-I was administered in 6 group sessions.
  • Standardized questionnaires including the Athens Insomnia Scale (AIS) and Beck Depression Inventory (BDI) were used for outcome assessment.

Main Results:

  • CBT-I significantly improved all measured sleep parameters, including sleep latency, efficiency, and quality.
  • Insomnia patients showed reduced depression and anxiety symptoms, and improved daytime functioning post-treatment.
  • Improvements were maintained at a 3-month follow-up, with patients nearing control group levels in several domains.

Conclusions:

  • Cognitive Behavioral Therapy for Insomnia (CBT-I) offers a sustained and clinically meaningful improvement for chronic insomnia.
  • CBT-I effectively enhances both nocturnal sleep and overall daytime functioning.
  • The treatment demonstrates long-term efficacy, making it a valuable therapeutic option.